C. Chenwi

发表

Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon

V. Colizzi, J. Torimiro, J. Fokam, 2020, Virology Journal.

HPV Positivity and Risk of Cervical Cancer according to HIV-Infection: A Comparative Assessment in the Population of Cameroonian Women

V. Colizzi, S. Billong, Z. Sando, 2021 .

Archiving of mutations in HIV‐1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP‐READY study

V. Colizzi, C. Perno, M. Santoro, 2021, HIV medicine.

High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness

V. Colizzi, C. Perno, Z. Sando, 2022, IJID Regions.

Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings

C. Tchiégang, A. Nanfack, A. Ndjolo, 2020, BMC Infectious Diseases.

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Viruses.

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Microbiology spectrum.

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, Diagnostic microbiology and infectious disease.

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, The Journal of antimicrobial chemotherapy.

Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID‐19 pandemic

F. Ceccherini‐Silberstein, Y. Boum, V. Colizzi, 2023, HIV medicine.

Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa

E. Buratti, L. De Conti, C. Stuani, 2021, EClinicalMedicine.

High viremia and Poor Immunity are Potential Surrogates of Anti-toxoplasmic Immunoglobulin G Quantification among HIV-Infected Individuals: A Cross-sectional Study in Yaoundé, Cameroon

V. Colizzi, J. Fokam, A. Ndjolo, 2020 .

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2023, Viruses.

Increased Risk of Arterial Stiffness in Rhumatoid Arthritis Patients in a Sub-Saharan African Setting

J. Nkeck, D. Lemogoum, M. Doualla, 2023, World Journal of Cardiovascular Diseases.

Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population

V. Colizzi, S. Billong, Z. Sando, 2023, Journal of Public Health in Africa.

Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

V. Colizzi, C. Perno, J. Fokam, 2023, Pathogens.

Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa

F. Ceccherini‐Silberstein, V. Colizzi, M. Santoro, 2024, Journal of virus eradication.

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2023, Viruses.

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study

V. Colizzi, C. Perno, M. Santoro, 2023, PloS one.